Improving Compassion Satisfaction Amid a Nursing Shortage
A nationwide nursing shortage is not only reducing the amount of time oncology nurses have to spend with their patients, but also increasing the risk for burnout and compassion fatigue.
Related Articles
APP Experience Can Garner Conversations Around Restaging of Cancer
Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.
Cema-Cel Yields CR, Found Tolerable in CD19 CAR T-Cell Therapy–Naive R/R LBCL
Cema-cel was associated with largely durable CRs in patients with CD19 CAR T-cell therapy-naïve relapsed/refractory LBCL.
Splashblocker May Reduce Toilet Plume Aerosols in Oncology Setting
While ambient particle levels differed by HEPA filter status, Splashblocker significantly reduced particles emitted from toilet plume aerosols regardless.
Approvals in Cancer Care Call for Multidisciplinary Cooperation
Working with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.
Interdisciplinary Collaboration ‘Imperative’ to Streamlining Cancer Care
Working with interdisciplinary teams and nurse navigators to coordinate care across specialties is a facet of oncology nursing that may be overlooked, says an expert.
Mobile App May Be Feasible for Tracking Oral Cancer Medication Adherence
Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at baseline saw some increase in adherence.
Older Patients with Lenalidomide-Refractory MM May Face Treatment Gaps
Real-world data show that older adults with lenalidomide-refractory MM have poor survival outcomes after 1 to 3 lines of therapy.
Rusfertide Plus SOC Reaches Response End Point in Phlebotomy-Dependent PV
Clinical response rates were higher in patients with phlebotomy-dependent polycythemia vera who received rusfertide than in those who received placebo.
PYX-201 Receives FDA Fast Track Designation for Recurrent/Metastatic HNSCC
The FDA has granted PYX-201 fast track designation for treatment of recurrent or metastatic HNSCC after progression post-chemoimmunotherapy.
Keeping Up With Cancer Research to Provide Patients With Up-to-Date Care
Staying up to date with data from trials and information from organizations dedicated to cancer research is crucial for oncology nurses and APPs.